SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-24-001753
Filing Date
2024-02-27
Accepted
2024-02-27 15:32:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 d10982711_13g.htm SC 13G 99382
  Complete submission text file 0000919574-24-001753.txt   100939
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 24686012
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 1189 WILMETTE AVENUE #216 WILMETTE IL 60091
Business Address
Callahan Patrick J. III (Filed by) CIK: 0002011861 (see all company filings)

Type: SC 13G